
아스텔라스제약 웹사이트를
방문해 주셔서 감사합니다.
외부 사이트로 이동합니다.
본 웹사이트에는 모든 국가에서 판매되지 않거나, 별도의 지시사항 또는 투약방법이 표기되어 개별 상표로 판매될 수 있는 제품에 관한 정보가 포함되어 있습니다. 따라서 본 웹사이트에서 소개된 내용으로, 개발 중에 있는 제품을 포함한 어떠한 약품에 관한 권유나 홍보, 광고를 할 수 없습니다.
본 웹사이트에 들어있는 제품에 관한 정보는 의료적인 조언을 제시하기 위한 것이 아니며, 의사나 의료 제공업체가 제시하는 조언 대신 사용해서도 안 됩니다.
Materiality in CSR activities guides our CSR-based management. Astellas has identified material issues to be addressed based on the issues regarded as prerequisites of its business activities. These include global issues related to medical care and health and other broader social issues.
Making reference to expectations and requests from a broad range of stakeholders, we classified and prioritized the material issues into three categories by evaluating their social significance and relevance to our business (CSR Materiality Matrix.) In order to tackle these material issues, we are executing a concrete action plan.
Step 1
Identify Issues
Astellas' material issues are identified with reference to various principles and guidelines (such as ISO 26000, the UN Global Compact's ten principles and the SASB* Materiality Map), communications with stakeholders, and evaluation items for Socially Responsible Investment (SRI) indices, etc.
* SASB: Sustainability Accounting Standards Board.
A U.S. non-profit organization exploring disclosure standards for non-financial information on an industry-by-industry basis. SASB has prepared industry-specific materiality maps by evaluating the materiality of 43 factors related to the environment, society and governance.
Step 2
Prioritize
We will prioritize Astellas' material issues from the dual perspectives of societal significance and relevance to our business.
Step 3
Review
Astellas' material issues will be periodically reviewed and verified. They will be modified depending on the attainment level of initiatives implemented and/or any changes in society's demands.